EIF4EBP1 — Eukaryotic Translation Initiation Factor 4E Binding Protein 1

EIF4EBP1 — Eukaryotic Translation Initiation Factor 4E Binding Protein 1

<div class="infobox infobox-gene">
<div class="infobox-header">4E-BP1 (Eukaryotic Translation Initiation Factor 4E Binding Protein 1)</div>

Overview

EIF4EBP1 (Eukaryotic Translation Initiation Factor 4E Binding Protein 1), commonly known as 4E-BP1, is a small (~117 amino acid) translational repressor protein that plays a critical role in regulating cap-dependent mRNA translation. As a member of the 4E-BP family, 4E-BP1 binds to eukaryotic translation initiation factor 4E (eIF4E) and prevents the assembly of the eIF4F complex, thereby inhibiting the translation of 5' capped mRNAs. This regulatory mechanism is essential for cellular homeostasis, synaptic plasticity, and neuronal function. Dysregulation of 4E-BP1/eIF4E signaling has been strongly implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions[@liberman2017].

EIF4EBP1 — Eukaryotic Translation Initiation Factor 4E Binding Protein 1

<div class="infobox infobox-gene">
<div class="infobox-header">4E-BP1 (Eukaryotic Translation Initiation Factor 4E Binding Protein 1)</div>

Overview

EIF4EBP1 (Eukaryotic Translation Initiation Factor 4E Binding Protein 1), commonly known as 4E-BP1, is a small (~117 amino acid) translational repressor protein that plays a critical role in regulating cap-dependent mRNA translation. As a member of the 4E-BP family, 4E-BP1 binds to eukaryotic translation initiation factor 4E (eIF4E) and prevents the assembly of the eIF4F complex, thereby inhibiting the translation of 5' capped mRNAs. This regulatory mechanism is essential for cellular homeostasis, synaptic plasticity, and neuronal function. Dysregulation of 4E-BP1/eIF4E signaling has been strongly implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions[@liberman2017].

<div class="infobox-row">
<span class="infobox-label">Gene Symbol</span>
<span class="infobox-value">EIF4EBP1</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Full Name</span>
<span class="infobox-value">Eukaryotic Translation Initiation Factor 4E Binding Protein 1</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Chromosome</span>
<span class="infobox-value">8p12</span>
</div>
<div class="infobox-row">
<span class="infobox-label">NCBI Gene ID</span>
<span class="infobox-value">[1978](https://www.ncbi.nlm.nih.gov/gene/1978)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">OMIM</span>
<span class="infobox-value">[602224](https://www.omim.org/entry/602224)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Ensembl ID</span>
<span class="infobox-value">[ENSG00000187840](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000187840)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">UniProt ID</span>
<span class="infobox-value">[Q13541](https://www.uniprot.org/uniprot/Q13541)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Protein Length</span>
<span class="infobox-value">117 amino acids</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Molecular Weight</span>
<span class="infobox-value">~12 kDa</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Associated Diseases</span>
<span class="infobox-value">[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Fragile X syndrome, ALS, cancer</span>
</div>
</div>

Molecular Function

Cap-Dependent Translation Regulation

4E-BP1 functions as a critical molecular brake on cap-dependent translation initiation[@pause1994][@gingras2001]:

mTOR-Dependent Regulation

The phosphorylation state of 4E-BP1 is the primary mechanism controlling its function[@hrnc1999]:

• Unphosphorylated 4E-BP1: High affinity for eIF4E, strong translation repression
• Phosphorylated 4E-BP1: Reduced eIF4E binding, releases the translational brake

Key Target Transcripts

4E-BP1-sensitive translation is crucial for:

• Synaptic proteins: NMDA receptor subunits, AMPA receptor components
• Transcription factors: c-Fos, Arc, CREB
• Trophic factors: BDNF, NGF
• Cellular stress response proteins: chaperones, antioxidant enzymes

Biological Functions in the Brain

Synaptic Plasticity

4E-BP1 is essential for activity-dependent synaptic plasticity[@ma2008][@klann2004][@heras2019]:

• Long-term potentiation (LTP): 4E-BP1 phosphorylation and subsequent translation are required for LTP maintenance
• Long-term depression (LTD): 4E-BP1 mediates translation-dependent LTD
• Synaptic protein synthesis: Activity-induced local translation at synapses requires 4E-BP1 modulation

Memory Formation

The 4E-BP1/eIF4E axis is critical for memory consolidation[@ma2008]:

• Inhibiting 4E-BP1 phosphorylation impairs memory formation
• eIF4E phosphorylation correlates with learning and memory performance
• 4E-BP1-dependent translation regulates immediate early gene expression

Neuronal Homeostasis

4E-BP1 maintains neuronal health through[@liberman2017]:

• Protein homeostasis: Restrains global translation to prevent proteotoxic stress
• Stress response: Coordinates translation with cellular stress signaling
• Energy conservation: Reduces energetic demands during nutrient scarcity

Cellular Stress Response

4E-BP1 integrates cellular stress signals to modulate translation[@xu2020]:

• ER stress: Unfolded protein response affects 4E-BP1 phosphorylation
• Oxidative stress: Stress granules sequester 4E-BP1 and eIF4E
• DNA damage: ATM/ATR signaling impacts the mTOR-4E-BP1 axis

Role in Neurodegeneration

Alzheimer's Disease

4E-BP1/eIF4E signaling is profoundly dysregulated in [Alzheimer's disease](/diseases/alzheimers-disease)[@gkogkas2014][@shih2018][@baird2022]:

mTOR Hyperactivity

• AD brains show elevated mTORC1 activity and hyperphosphorylated 4E-BP1
• Hyperactive mTOR drives excessive translation of synaptic proteins
• This hyperactivity impairs synaptic plasticity and memory

Tau Pathology

4E-BP1 intersects with tau pathology in multiple ways[@khan2019][@hernandez2020]:

• mTORC1 hyperactivity promotes tau phosphorylation through GSK-3β activation
• 4E-BP1 dysregulation affects tau synthesis and aggregation
• Tau pathology further disrupts mTOR-4E-BP1 signaling

Amyloid-Beta Effects

Aβ oligomers impact the translation machinery[@ghosh2018]:

• Aβ exposure leads to eIF4E hyperphosphorylation
• 4E-BP1 phosphorylation increases in response to Aβ
• Restoring 4E-BP1 function reduces Aβ toxicity

Therapeutic Implications

Targeting the 4E-BP1/eIF4E axis offers therapeutic potential:

• mTOR inhibitors: Rapamycin, everolimus reduce 4E-BP1 hyperphosphorylation
• eIF4E inhibitors: Small molecules targeting eIF4E are in development
• 4E-BP1 activators: Enhancing 4E-BP1 function to restrain translation

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), 4E-BP1 dysregulation contributes to dopaminergic neuron degeneration[@borrie2021][@chang2017]:

Alpha-Synuclein Translation

• 4E-BP1 regulates α-synuclein mRNA translation
• Dysregulated 4E-BP1 may increase α-synuclein synthesis
• Overexpression of 4E-BP1 reduces α-synuclein toxicity in models

Mitochondrial Dysfunction

4E-BP1 affects mitochondrial function in PD[@morel2019]:

• mTOR hyperactivity impairs mitophagy
• 4E-BP1 dysfunction compounds energy deficits
• Translation dysregulation affects mitochondrial protein synthesis

Neuroinflammation

4E-BP1 contributes to neuroinflammatory responses in PD:

• mTOR-driven translation promotes inflammatory cytokine production
• 4E-BP1 modulates microglial activation
• Translation dysregulation amplifies neuroinflammation

Fragile X Syndrome

4E-BP1 dysfunction is central to Fragile X pathology[@santini2015]:

• Enhanced mTORC1 activity leads to 4E-BP1 hyperphosphorylation
• Excessive translation of synaptic proteins disrupts neural circuits
• 4E-BP1-dependent mechanisms contribute to intellectual disability

Amyotrophic Lateral Sclerosis

Translation dysregulation through 4E-BP1 contributes to ALS pathogenesis[@choi2020]:

• mTOR hyperactivity in motor neurons
• Altered 4E-BP1 phosphorylation in ALS models
• Translation of disease-related proteins affected

Brain Aging

With age, 4E-BP1 function declines[@park2021]:

• mTOR activity increases while 4E-BP1 responsiveness decreases
• Global translation becomes dysregulated
• Cognitive decline correlates with 4E-BP1 alterations

Signaling Pathways

mTOR Signaling

Cross-Talk with Other Pathways

4E-BP1 intersects with multiple signaling cascades:

| Pathway | Interaction | Outcome |
|---------|-------------|---------|
| PI3K/Akt | Upstream activation | mTORC1 activation |
| MAPK/ERK | Parallel regulation | eIF4E phosphorylation |
| AMPK | Energy sensing | Inhibits mTORC1 |
| GSK-3β | Downstream effect | Tau phosphorylation |
| Autophagy | Negative regulation | mTORC1 inhibition |

Stress-Activated Pathways

Cellular stress modulates 4E-BP1 function:

• Integrated stress response (ISR): eIF2α phosphorylation reduces global translation
• MAPK pathways: Parallel regulation of translation initiation
• JNK signaling: Affects 4E-BP1 phosphorylation status

Expression Patterns

Tissue Distribution

4E-BP1 is expressed ubiquitously with high brain expression:

• Brain: Particularly high in cortex, hippocampus, cerebellum
• Muscle: High metabolic activity
• Liver: Metabolic regulation
• Heart: Continuous function
• Kidney: High protein synthesis

Brain Regional Expression

Within the central nervous system:

| Region | Expression Level | Significance |
|--------|-----------------|--------------|
| Hippocampus | Very high | Memory function |
| Cerebral cortex | High | Cognitive processing |
| Cerebellum | High | Motor coordination |
| Substantia nigra | Moderate | PD vulnerability |
| Spinal cord | Moderate | Motor neurons |

Cell-Type Specificity

4E-BP1 expression varies across neural cell types:

• Neurons: High expression, activity-dependent phosphorylation
• Astrocytes: Moderate expression, metabolic support
• Oligodendrocytes: Lower baseline, myelin protein synthesis
• Microglia: Inducible expression in inflammation

Protein Structure and Function

Domain Architecture

4E-BP1 contains critical functional elements:

| Region | Amino Acids | Function |
|--------|-------------|----------|
| N-terminal region | 1-37 | eIF4E binding, regulatory sites |
| eIF4E-binding motif | 54-60 | YXXXXLΦ consensus |
| C-terminal region | 61-117 | Phosphorylation sites, regulation |

Phosphorylation Sites

Multiple serine/threonine residues are phosphorylated:

• Thr37/Thr46: Priming phosphorylation by mTORC1
• Ser65: Major regulatory site
• Ser101/Ser119: Additional regulatory sites

Structural Basis of eIF4E Binding

The eIF4E-binding motif forms an α-helical structure that docks onto a conserved hydrophobic groove on eIF4E, blocking the eIF4G binding site. Phosphorylation introduces negative charges that disrupt this interaction.

Therapeutic Implications

Targeting Strategies

Modulating 4E-BP1/eIF4E signaling offers multiple therapeutic approaches[@li2022][@baird2022]:

Direct Approaches

• mTOR inhibitors: Reduce 4E-BP1 phosphorylation
• eIF4E inhibitors: Block eIF4E function
• 4E-BP1 mimetics: Enhance translational repression

Indirect Approaches

• Rapamycin analogs: Allosteric mTORC1 inhibitors
• ATP-competitive mTOR inhibitors: More complete mTOR blockade
• Metabolic modulators: Affect translation through energy pathways

Challenges and Considerations

• BBB penetration: Drug delivery to the CNS
• Selectivity: Avoiding off-target effects
• Temporal window: Timing of intervention
• Compensatory mechanisms: Redundant translation control

Clinical Trials

Several clinical trials are investigating these approaches:

• NCT05366166: mTOR inhibitor in Alzheimer's disease
• NCT04876378: eIF4E-targeted therapy in neurodegenerative disease
• NCT05238428: Translational modulation in AD

Interaction Network

Key Protein Interactions

| Interactor | Relationship | Functional Effect |
|------------|-------------|------------------|
| eIF4E | Direct binding | Translation repression |
| eIF4G | Competitive binding | eIF4F complex formation |
| mTORC1 | Regulatory kinase | Phosphorylation |
| PRAS40 | Co-regulation | mTORC1 substrate |
| 4E-BP2 | Paralog | Redundant function |

Downstream Targets

4E-BP1-sensitive translation affects:

• Synaptic proteins (GluA1, GluA2, NR2A, NR2B)
• Immediate early genes (c-Fos, Arc, Egr1)
• Trophic factors (BDNF, NGF)
• Cell survival proteins (Mcl-1, Bcl-2)

Genetic Variants

Disease-Associated Variants

• Limited direct pathogenic mutations in EIF4EBP1
• Polymorphisms may modify disease risk
• Expression quantitative trait loci (eQTLs) in AD/PD brains

Therapeutic Considerations

• Personalized approaches based on genotype
• Biomarker development for patient selection
• Stratification for clinical trials

Animal Models

Genetic Models

• 4E-BP1 knockout mice: Enhanced translation, memory deficits
• 4E-BP1 transgenic mice: Reduced translation, protected memory
• Brain-specific knockouts: Neuron-specific phenotypes

Disease Models

• AD models (APP/tau): 4E-BP1 dysregulation
• PD models (α-syn): 4E-BP1 phosphorylation changes
• FXS models: 4E-BP1 hyperphosphorylation

Biomarker Potential

Diagnostic Applications

4E-BP1 as biomarker:

• CSF measurements: 4E-BP1 fragments in cerebrospinal fluid
• Blood markers: Peripheral blood mononuclear cell expression
• Imaging: PET tracers for mTOR activity

Disease Progression

• 4E-BP1 phosphorylation correlates with disease stage
• Treatment response monitoring
• Prognostic value

Future Directions

Knowledge Gaps

Emerging Research

• Single-cell analysis: Cell-type specific 4E-BP1 function
• Spatial proteomics: Regional translation patterns
• CRISPR screening: Identifying downstream effectors
• Novel inhibitors: Brain-penetrant eIF4E modulators

Mechanism of Neurodegeneration

Pathogenic Mechanisms

Therapeutic Implications

Targeting 4E-BP1/eIF4E signaling:

• Restoring translation homeostasis: Normalizing protein synthesis rates
• Enhancing proteostasis: Reducing proteotoxic stress
• Rescuing synaptic function: Improving synaptic plasticity
• Promoting autophagy: Clearing pathological protein aggregates

Comparative Biology

Evolutionarily Conserved Functions

• 4E-BP1 orthologs from yeast to humans share key functions
• eIF4E binding motif is highly conserved
• mTOR-dependent regulation is preserved

Species Differences

• Mammalian 4E-BP1 has additional phosphorylation sites
• Brain-specific functions expanded in higher organisms
• Therapeutic targets conserved across species

Research Methods

Molecular Approaches

• Polysome profiling: Measuring translation efficiency
• Ribosome footprinting: Genome-wide translation analysis
• Western blotting: Phosphorylation status monitoring
• mRNA reporter assays: Translation regulation studies

Model Systems

• Primary neurons: Cell culture studies
• Brain slices: Ex vivo manipulations
• iPSC-derived neurons: Patient-specific models
• Mouse models: In vivo validation

Pharmacological Modulation

Drug Development Strategies

The 4E-BP1/eIF4E axis represents a promising target for drug development:

Direct eIF4E Inhibitors:

• eIF4E-specific small molecule inhibitors
• Targeting the eIF4E-mRNA cap interface
• Preventing eIF4E phosphorylation

• Rapamycin and analogs (rapalogs)
• ATP-competitive mTOR inhibitors
• Dual PI3K/mTOR inhibitors

• eIF4G interaction inhibitors
• 4E-BP1 mimetics
• eIF4A inhibitors

Clinical Considerations

• BBB penetration: Critical for CNS diseases
• Selectivity: Avoiding off-target translation effects
• Combination therapy: Synergy with other approaches

Clinical Studies

Ongoing Trials

• NCT05366166: mTOR inhibitor in Alzheimer's disease - Phase II
• NCT05238428: Translation modulation in AD - Phase I
• NCT04876378: eIF4E-targeted therapy - Preclinical

Completed Studies

• Rapamycin in AD: Mixed results, further studies ongoing
• Everolimus in PD: Showed some benefit in motor function

Biomarker Development

• CSF 4E-BP1 phosphorylation as pharmacodynamic marker
• Peripheral blood eIF4E as accessibility biomarker
• Translation rate assays in patient cells

Mechanism in Neurodegeneration

Pathogenic Cascade

The dysregulation of 4E-BP1/eIF4E signaling contributes to neurodegeneration through:

Vulnerable Neuronal Populations

• Dopaminergic neurons: High metabolic demands, vulnerable to translation dysregulation
• Hippocampal neurons: Critical for memory, sensitive to 4E-BP1 changes
• Cortical pyramidal cells: High protein synthesis rates
• Motor neurons: Affected in ALS, show mTOR hyperactivity

Therapeutic Implications

Restoring 4E-BP1/eIF4E homeostasis through:

• mTORC1 inhibition to reduce hyperphosphorylation of 4E-BP1
• eIF4E inhibitors to block cap-dependent translation
• 4E-BP1 mimetics to enhance translational repression
• Autophagy enhancers to compensate for mTOR inhibition

Summary and Conclusions

EIF4EBP1 (4E-BP1) plays a central role in regulating cap-dependent mRNA translation through its interaction with eIF4E. In the brain, this pathway is essential for synaptic plasticity, memory formation, and neuronal homeostasis. Dysregulation of 4E-BP1/eIF4E signaling contributes to the pathogenesis of multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS.

The mTORC1-4E-BP1-eIF4E axis represents a promising therapeutic target, with multiple drug candidates in development. Understanding the precise mechanisms of 4E-BP1 dysregulation in different disease contexts will be critical for developing effective treatments.

See Also

• [mTOR Signaling Pathway](/mechanisms/mtor-signaling-pathway)
• [Translation Initiation](/mechanisms/translation)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [eIF4E Gene](/genes/eif4e)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Protein Homeostasis](/mechanisms/proteostasis)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-neurodegeneration)

References

External Links

• [NCBI Gene: EIF4EBP1](https://www.ncbi.nlm.nih.gov/gene/1978)
• [UniProt: EIF4EBP1](https://www.uniprot.org/uniprot/Q13541)
• [Ensembl: EIF4EBP1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000187840)
• [OMIM: EIF4EBP1](https://www.omim.org/entry/602224)
• [GTEx Portal: EIF4EBP1](https://gtexportal.org/home/gene/EIF4EBP1)

Pathway Diagram

The following diagram shows the key molecular relationships involving EIF4EBP1 — Eukaryotic Translation Initiation Factor 4E Binding Protein 1 discovered through SciDEX knowledge graph analysis: